In a market saturated with synthetic supplements, Graminex is betting the farm—literally—on flower pollen. This isn't another wellness startup chasing trends; it's a specialized grower and manufacturer that has quietly dominated a niche of botanical extracts for decades, completing clinical trials for women's urinary incontinence while flying under the radar of mainstream investors.

"Aside from you, nature is our only partner.™ This isn't marketing fluff—it's a vertically integrated supply chain."

The company's leadership structure reveals a family-run operation with Heather May as CEO, Cynthia May as Owner/CEO, and Colleen May as Chief Business Officer. This familial approach likely contributes to their long-term vision and stability—rare traits in the health supplement industry where churn is common. Their focus on non-solvent flower pollen extracts positions them in a premium segment, avoiding the commoditization trap that plagues many supplement manufacturers.

• Clinical validation: Completed trials for women's urinary incontinence, moving beyond anecdotal claims
• Specialized focus: Non-solvent extraction methods preserve bioactive compounds
• Vertical integration: From cultivation to manufacturing under one roof
• Stable leadership: Family-run with clear succession and long-term vision